Softwr

Research · head to head

Medidata Rave vs Signant Health

Medidata Rave logo

Medidata Rave

Research

Electronic data capture for regulated clinical trials, sold only through a sales process

From
On request
Rated
-
Full reviewWebsite
Signant Health logo

Signant Health

Healthcare

eCOA-first clinical trial platform that has grown outward into EDC, eConsent and televisits

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Medidata Rave no pricing is published at all, so a first time sponsor cannot budget a study without entering a sales process and usually cannot benchmark the quote against anything.; Signant Health no pricing is published, and the software licence is a minority of the real bill once instrument licensing, translations, device provisioning and services are added, so early budget estimates are routinely too low.
  • They diverge on capability: Medidata Rave covers Case report form design, Signant Health covers eCOA and ePRO.
  • Prices and features above were last checked on 31 August 2026.

Where they differ

Only the attributes on which Medidata Rave and Signant Health actually diverge.

Attributes where Medidata Rave and Signant Health differ
AttributeMedidata RaveSignant Health
PlatformsWebWeb, iOS, Android
CategoryResearchHealthcare

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Medidata Rave

  • Case report form design
  • Edit checks and queries
  • Part 11 audit trail
  • Rave Lite
  • Coding and safety
  • Platform integrations

Only in Signant Health

  • eCOA and ePRO
  • Unified platform
  • eConsent
  • Randomisation and supplies
  • TeleVisits
  • Rater training
  • Data surveillance
  • Instrument library

What people use each for

The jobs each tool is most often brought in to do.

Medidata Rave

  • A sponsor running a registrational Phase III study where inspection readiness and a validated audit trail are non negotiablenot Signant Health
  • A biotech that wants its CRO to run data management and benefits from the CRO already having Rave trained staff and templatesnot Signant Health
  • A sponsor standardising forms across a programme so that a global library is reused rather than each study being built from scratchnot Signant Health
  • A device or Phase IV study where Rave Lite gives the same compliance posture at a lower configuration burdennot Signant Health

Signant Health

  • A central nervous system or psychiatry trial where the primary endpoint is a rated scale and rater consistency decides the readoutnot Medidata Rave
  • A global study needing an outcome instrument translated and linguistically validated across a dozen languagesnot Medidata Rave
  • A decentralised or hybrid protocol combining televisits, eConsent and at-home patient reported outcomesnot Medidata Rave
  • A sponsor consolidating separate eCOA, eConsent and randomisation vendors onto one platform to cut reconciliation worknot Medidata Rave

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Medidata Rave

  • No pricing is published at all, so a first time sponsor cannot budget a study without entering a sales process and usually cannot benchmark the quote against anything.
  • Cost is dominated by study build rather than licence, and every protocol amendment that changes a form triggers billable rework, so a study with unstable protocols costs far more than the initial quote implied.
  • Configuration requires trained specialists, so most sponsors cannot build a study in house and are dependent on Medidata professional services or a CRO, which lengthens startup.
  • The system assumes a professional clinical data management function; a small sponsor without data managers will not operate it directly and will pay a CRO to do so.
  • Deep use of the wider Medidata platform for randomisation, imaging and patient reported data creates commercial lock in, because moving EDC later means unpicking integrations that were bought as one bundle.

Signant Health

  • No pricing is published, and the software licence is a minority of the real bill once instrument licensing, translations, device provisioning and services are added, so early budget estimates are routinely too low.
  • Linguistic validation is charged per instrument per language and is on the critical path to first patient in, so adding a country late in start-up produces both a cost and a schedule hit.
  • Provisioned participant devices bring logistics, replacement, shipping and cellular connectivity obligations that persist for the life of the trial and are frequently underestimated.
  • The EDC component is newer than the eCOA heritage, so sponsors with complex data management requirements often keep an incumbent EDC and lose the single-database benefit that justifies the platform.
  • It is priced and scoped for sponsor-grade trials, which makes it a poor fit for investigator-initiated or academic studies that need outcome collection without the services layer.

Pricing, plan by plan

Medidata Rave

On request
  • Medidata Rave EDC$undefined/year
    • Priced per study through a sales process
    • Study build and configuration charged separately from licence
    • Mid study amendments generally billable

Signant Health

On request
  • SmartSignals Unified Platform$undefined/year
    • Priced per study through a sales process
    • Modules selected per protocol: EDC, eCOA, randomisation, eConsent, TeleVisits
    • Instrument licensing paid to scale owners on top of platform cost

Which should you pick?

Choose Medidata Rave if

  • You need case report form design.
  • You also want edit checks and queries.
Medidata Rave review

Choose Signant Health if

  • You need ecoa and epro.
  • You work on Web, iOS, Android.
  • You also want unified platform.
Signant Health review

Questions people ask

Is Medidata Rave or Signant Health better?
Neither clearly leads. Medidata Rave starts at On request and Signant Health at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Medidata Rave or Signant Health?
Medidata Rave starts at On request and Signant Health at On request.
Does Medidata Rave or Signant Health run on more platforms?
Medidata Rave runs on Web. Signant Health runs on Web, iOS, Android.
What is Medidata Rave best used for?
Medidata Rave is most often used for a sponsor running a registrational phase iii study where inspection readiness and a validated audit trail are non negotiable, a biotech that wants its cro to run data management and benefits from the cro already having rave trained staff and templates, a sponsor standardising forms across a programme so that a global library is reused rather than each study being built from scratch, a device or phase iv study where rave lite gives the same compliance posture at a lower configuration burden. Of those, a sponsor running a registrational phase iii study where inspection readiness and a validated audit trail are non negotiable and a biotech that wants its cro to run data management and benefits from the cro already having rave trained staff and templates are not what Signant Health is typically brought in for.
What can Medidata Rave do that Signant Health cannot?
Medidata Rave covers Case report form design, Edit checks and queries, Part 11 audit trail, Rave Lite. Signant Health covers eCOA and ePRO, Unified platform, eConsent, Randomisation and supplies.

Answered from the vendors’ own pages

Medidata Rave: Who owns Medidata?

Dassault Systemes, which acquired Medidata in 2019. Rave is sold as part of the Dassault life sciences portfolio.

Signant Health: What is Signant best at?

Electronic clinical outcome assessment, particularly rated scales in central nervous system and psychiatry trials, together with rater training and endpoint quality services.

Medidata Rave: How is Rave priced?

Per study, through a sales process. Nothing is published, and study build and amendments are charged separately from the licence.

Signant Health: Is pricing published?

No. Everything is quoted per study, and instrument licences, translations and devices sit on top of the platform cost.

Medidata Rave: Is Rave validated out of the box?

Medidata supplies validation and qualification documentation, but the sponsor still owns study level user acceptance testing and its own validation evidence.

Signant Health: Can I use it only for eCOA?

Yes. The modules are selected per protocol, and many sponsors take eCOA and eConsent while keeping an existing EDC.

Medidata Rave: What is Rave Lite for?

Lower complexity studies, typically Phase I, Phase IV and medical device, where a full study build is not justified.

Signant Health: What drives the timeline?

Translation and linguistic validation of outcome instruments, which is per language per instrument and sits on the critical path to study start.

Share

Related pages

More on Medidata Rave

More on Signant Health

Keep looking

Other head to heads